Second cancers non-Hodgkin lymphoma risk second malignancies non-Hodgkin lymphoma NHL patients NHL areas National Cancer Institute Surveillance Epidemiology End Results Program Compared general population NHL patients risk second cancers O/E O/E ratio time survivors Significant excesses acute nonlymphocytic leukemia O/E cancers bladder O/E kidney O/E lung O/E malignant melanoma O/E Hodgkin disease O/E Chemotherapy subsequent acute nonlymphocytic leukemia ANLL bladder cancer Radiation therapy ANLL cancers lung bladder bone Malignant melanoma initial NHL treatment 